TITLE

Pregabalin/CNS depressants

PUB. DATE
November 2017
SOURCE
Reactions Weekly;11/18/2017, Vol. 1678 Issue 1, p148
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
126306640

 

Related Articles

  • BOOKS RECEIVED.  // Clinical Pediatrics;Feb1980, Vol. 19 Issue 2, p127 

    This article presents a list of books received for publication in the February 1980 issue of the journal "Clinical Pediatrics." Some of the books listed are "Maternal Nutrition and Child Health," "Dietary Guidelines," "Quick Reference to Clinical Nutrition," "Paediatric Otolaryngology,"...

  • Book Review. Damjanov, Nevena // Modern Pathology;Sep2000, Vol. 13 Issue 9, p953 

    Reviews the book "Anticancer Drug Toxicity Prevention, Management, and Clinical Pharmacokinetics," edited by H.P. Lipp.

  • Watch your poison. Herxheimer, Andrew // British Medical Journal;8/25/1979, Vol. 2 Issue 6188, p488 

    Reviews the book 'Drug Toxicity,' edited by J.W. Gorrod.

  • High-Dose Interleukin-2. Portillas, Rusticio; Turner, Barbara; Jeffers, Audrey; Chen, Lee-Lynn; Champagne, Mary // Clinical Journal of Oncology Nursing;Apr2017, Vol. 21 Issue 2, pE49 

    BACKGROUND: Life-threatening toxicity may result from administration of high-dose (HD) interleukin-2 (IL-2). Patients receiving HD IL-2 treatment often experience severe adverse side effects, which result in the interruption of treatment. OBJECTIVES: A standardized order set (SOS) was developed...

  • Immunotherapy Toxicities. Reimschissel, Elizabeth; Dela Cruz, Buenagracia; Gonzalez, Melissa; Buitrago, Joaquin; Goodman, Cary; Johnston, Patricia A. // Clinical Journal of Oncology Nursing;Apr2017, Vol. 21 Issue 2, p41 

    BACKGROUND: Emerging immunotherapies are associated with numerous toxicities. Although traditional health records allow nurses to document system-based assessments, few offer immunotherapy-based documentation templates to assess and grade toxicities. OBJECTIVES: The aim of this article is to...

  • Checkpoint Inhibitors. Gordon, RuthAnn; Kasler, Mary Kate; Stasi, Kristen; Shames, Yelena; Errante, Mimma; Ciccolini, Kathryn; Skripnik Lucas, Anna; Raasch, Pam; Fischer-Cartlidge, Erica // Clinical Journal of Oncology Nursing;Apr2017, Vol. 21 Issue 2, p45 

    BACKGROUND: Immunotherapy, specifically the use of checkpoint inhibitors, offers patients with cancer an alternative to chemotherapy, targeting different pathways to destroy cancer cells. The side effects of immunotherapies, as well as their impact on normal tissue, need to be assessed and...

  • Toxicity Management. Mistry, Haleigh E.; Forbes, Sheryl G.; Fowler, Nathan // Clinical Journal of Oncology Nursing;Apr2017, Vol. 21 Issue 2, p53 

    BACKGROUND: Novel immunotherapyand biologic agents are being developed with the potential to improve outcomes and reduce long-term toxicities among individuals with hematologic malignancies. These emerging drugs affect neoplastic cells and the surrounding microenvironment, causing unique...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics